183 related articles for article (PubMed ID: 25149983)
1. Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
Ciddi V; Dodda D
Pharmacol Rep; 2014 Oct; 66(5):799-803. PubMed ID: 25149983
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of pterostilbene for the management of diabetic complications.
Dodda D; Rama Rao A; Veeresham C
J Ayurveda Integr Med; 2020; 11(4):369-375. PubMed ID: 30459079
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
[TBL] [Abstract][Full Text] [Related]
4. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X
Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572
[TBL] [Abstract][Full Text] [Related]
6. Glucopyranoside flavonoids isolated from leaves of Spinacia oleracea (spinach) inhibit the formation of advanced glycation end products (AGEs) and aldose reductase activity (RLAR).
Perez Gutierrez RM; Velazquez EG
Biomed Pharmacother; 2020 Aug; 128():110299. PubMed ID: 32521451
[TBL] [Abstract][Full Text] [Related]
7. DW1029M, a novel botanical drug candidate, inhibits advanced glycation end-product formation, rat lens aldose reductase activity, and TGF-β1 signaling.
Yoon J; Lee H; Chang HB; Choi H; Kim YS; Rho YK; Seong S; Choi DH; Park D; Ku B
Am J Physiol Renal Physiol; 2014 May; 306(10):F1161-70. PubMed ID: 24694590
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory activities of the edible green alga Capsosiphon fulvescens on rat lens aldose reductase and advanced glycation end products formation.
Islam MN; Choi SH; Moon HE; Park JJ; Jung HA; Woo MH; Woo HC; Choi JS
Eur J Nutr; 2014 Feb; 53(1):233-42. PubMed ID: 23575770
[TBL] [Abstract][Full Text] [Related]
9. Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
Higashi Y; Higashi K; Mori A; Sakamoto K; Ishii K; Nakahara T
Biol Pharm Bull; 2018; 41(10):1586-1592. PubMed ID: 30270328
[TBL] [Abstract][Full Text] [Related]
10. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
11. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
Datiles MB; Fukui H
Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
[TBL] [Abstract][Full Text] [Related]
12. Delaying of cataract through intervention of Hemidesmus indicus in STZ induced diabetic rats.
Tirumani P; Venu S; Sridhar G; Praveen Kumar M; Rajashekhar AV; Naga Raju T
Nat Prod Res; 2018 Jun; 32(11):1295-1298. PubMed ID: 28580798
[TBL] [Abstract][Full Text] [Related]
13. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
14. 3,5-Di-O-caffeoyl-epi-quinic acid from the leaves and stems of Erigeron annuus inhibits protein glycation, aldose reductase, and cataractogenesis.
Jang DS; Yoo NH; Kim NH; Lee YM; Kim CS; Kim J; Kim JH; Kim JS
Biol Pharm Bull; 2010; 33(2):329-33. PubMed ID: 20118563
[TBL] [Abstract][Full Text] [Related]
15. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
Kim J; Kim CS; Sohn E; Lee YM; Kim JS
J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Drel VR; Pacher P; Ali TK; Shin J; Julius U; El-Remessy AB; Obrosova IG
Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
Singh A; Bodakhe SH
Curr Eye Res; 2021 Jan; 46(1):52-63. PubMed ID: 32631099
[TBL] [Abstract][Full Text] [Related]
18. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
19. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
20. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
